Fabrication of a Cell Fixation Device for Robotic Cell Microinjection

Automation of cell microinjection greatly reduces operational difficulty, but cell fixation remains a challenge. Here, we describe an innovative device that solves the fixation problem without single-cell operation. The microarray cylinder is designed with a polydimethylsiloxane (PDMS) material surface to control the contact force between cells and the material. Data show that when the injection velocity exceeds 1.5 mm/s, microinjection success rate is over 80%. The maximum value of the adhesion force between the PDMS plate and the cell is 0.0138 N, and the need can be met in practical use of the robotic microinjection

Electrical shielding for silicon nanowire biosensor in microchannels

When integrating silicon nanowire biosensors with a microfluidic sample delivery system, additional challenges are introduced. Noise and erroneous signal generation induced by sample fluidic handling such as flow rate fluctuations during sample switching reduce the quality and reliability of the measurement system. In this paper, we propose an effective electrical shielding method to improve the stability and reliability of the setup by placing double electrodes instead of a single electrode that is traditionally used for nanowire sensors. Experimental results show that with proper shielding electrical measurements are not influenced by flow speed variations or during sample switching

Heat-flux enhancement by vapour-bubble nucleation in Rayleigh-Bénard turbulence

We report on the enhancement of turbulent convective heat transport due to vapour-bubble nucleation at the bottom plate of a cylindrical Rayleigh–Bénard sample (aspect ratio 1.00, diameter 8.8 cm) filled with liquid. Microcavities acted as nucleation sites, allowing for well-controlled bubble nucleation. Only the central part of the bottom plate with a triangular array of microcavities (etched over an area with diameter of 2.5 cm) was heated. We studied the influence of the cavity density and of the superheat Tb−Ton (Tb is the bottom-plate temperature and Ton is the value of Tb below which no nucleation occurred). The effective thermal conductivity, as expressed by the Nusselt number Nu, was measured as a function of the superheat by varying Tb and keeping a fixed difference Tb−Tt≃16 K (Tt is the top-plate temperature). Initially Tb was much larger than Ton (large superheat), and the cavities vigorously nucleated vapour bubbles, resulting in two-phase flow. Reducing Tb in steps until it was below Ton resulted in cavity deactivation, i.e. in one-phase flow. Once all cavities were inactive, Tb was increased again, but they did not reactivate. This led to one-phase flow for positive superheat. The heat transport of both one- and two-phase flow under nominally the same thermal forcing and degree of superheat was measured. The Nusselt number of the two-phase flow was enhanced relative to the one-phase system by an amount that increased with increasing Tb. Varying the cavity density (69, 32, 3.2, 1.2 and 0.3 mm−2) had only a small effect on the global Nu enhancement; it was found that Nu per active site decreased as the cavity density increased. The heat-flux enhancement of an isolated nucleating site was found to be limited by the rate at which the cavity could generate bubbles. Local bulk temperatures of one- and two-phase flows were measured at two positions along the vertical centreline. Bubbles increased the liquid temperature (compared to one-phase flow) as they rose. The increase was correlated with the heat-flux enhancement. The temperature fluctuations, as well as local thermal gradients, were reduced (relative to one-phase flow) by the vapour bubbles. Blocking the large-scale circulation around the nucleating area, as well as increasing the effective buoyancy of the two-phase flow by thermally isolating the liquid column above the heated area, increased the heat-flux enhancement

Decreased P2 Waveform Reflects Impaired Brain Executive Function Induced by 12 h of Low Homeostatic Sleep Pressure: Evidence From an Event-Related Potential Study

Homeostatic sleep pressure can cause cognitive impairment, in which executive function is the most affected. Previous studies have mainly focused on high homeostatic sleep pressure (long-term sleep deprivation); thus, there is still little related neuro-psycho-physiological evidence based on low homeostatic sleep pressure (12 h of continuous wakefulness) that affects executive function. This study aimed to investigate the impact of lower homeostatic sleep pressure on executive function. Our study included 14 healthy young male participants tested using the Go/NoGo task in normal resting wakefulness (10:00 am) and after low homeostatic sleep pressure (10:00 pm). Behavioral data (response time and accuracy) were collected, and electroencephalogram (EEG) data were recorded simultaneously, using repeated measures analysis of variance for data analysis. Compared with resting wakefulness, the participants&#39; response time to the Go stimulus was shortened after low homeostatic sleep pressure, and the correct response rate was reduced. Furthermore, the peak amplitude of Go-P2 decreased significantly, and the peak latency did not change significantly. For NoGo stimulation, the peak amplitude of NoGo-P2 decreased significantly (p &lt; 0.05), and the peak latency was significantly extended (p &lt; 0.05). Thus, the P2 wave is likely related to the attention and visual processing and reflects the early judgment of the perceptual process. Therefore, the peak amplitude of Go-P2 and NoGo-P2 decreased, whereas the peak latency of NoGo-P2 increased, indicating that executive function is impaired after low homeostatic sleep pressure. This study has shown that the P2 wave is a sensitive indicator that reflects the effects of low homeostatic sleep pressure on executive function, and that it is also an important window to observe the effect of homeostatic sleep pressure and circadian rhythm on cognitive function.</p

The S-Nitrosylation Status of PCNA Localized in Cytosol Impacts the Apoptotic Pathway in a Parkinson’s Disease Paradigm

<div><p>It is generally accepted that nitric oxide (NO) or its derivatives, reactive nitrogen species (RNS), are involved in the development of Parkinson’s disease (PD). Recently, emerging evidence in the study of PD has indicated that protein S-nitrosylation triggers the signaling changes in neurons. In this study, SH-SY5Y cells treated with rotenone were used as a model of neuronal death in PD. The treated cells underwent significant apoptosis, which was accompanied by an increase in intracellular NO in a rotenone dose-dependent manner. The CyDye switch approach was employed to screen for changes in S-nitrosylated (SNO) proteins in response to the rotenone treatment. Seven proteins with increased S-nitrosylation were identified in the treated SH-SY5Y cells, which included proliferating cell nuclear antigen (PCNA). Although PCNA is generally located in the nucleus and participates in DNA replication and repair, significant PCNA was identified in the SH-SY5Y cytosol. Using immunoprecipitation and pull-down approaches, PCNA was found to interact with caspase-9; using mass spectrometry, the two cysteine residues PCNA-Cys81 and -Cys162 were identified as candidate S-nitrosylated residues. In addition, the evidence obtained from in vitro and the cell model studies indicated that the S-nitrosylation of PCNA-Cys81 affected the interaction between PCNA and caspase-9. Furthermore, the interaction of PCNA and caspase-9 partially blocked caspase-9 activation, indicating that the S-nitrosylation of cytosolic PCNA may be a mediator of the apoptotic pathway.</p></div

Localization of PCNA in SH-SY5Y cells.

<p>(A) Localization of PCNA in the cytosolic and nuclear fractions of SH-SY5Y cells was examined by Western blot with antibodies against PCNA, Lamin A (nuclei marker), and aldose reductase (AR, cytosolic marker). (B) Localization of PCNA in SH-SY5Y cells was observed by confocal microscopy. Signal for aldose reductase served as cytosolic marker. (C) Effect to the localization of PCNA in SH-SY5Y cells by rotenone treatment was monitored by confocal microscopy with immunofluorescence using the PCNA antibody. DAPI was used as a nuclei stain.</p

Effects of the S-nitrosylation status of PCNA on the interactions of PCNA and caspase-9.

<p>(A) Diagonal CoIP using two antibodies against PCNA and caspase-9 in SH-SY5Y cells. The interactions of PCNA and caspase-9 were negatively correlated with the NO contents in SH-SY5Y cells. L-NMMA was used for the inhibition of nNOS, and rabbit IgG was used as a negative control for immunoprecipitation. (B) The S-nitrosylation of recombinant PCNA, identified by BST/Western blot, using SNOC as a NO donor. (C) Comparison of the sensitivity of the potential cysteine residues of recombinant PCNA to S-nitrosylation under different NO stress levels. The sensitivity of cysteine residues to NO modification is represented as the ratios of the S-nitrosylated peptides identified by LC-MS/MS to the sum of the corresponding peptides, which include all S-nitrosylated and non-S-nitrosylated peptides at certain sites (n = 3, *P<0.05). (D) Effects of the PCNA mutants under NO stress on the interactions of PCNA and caspase-9. In the pull-down experiment, the wild-type PCNA and three PCNA mutants, PCNA-C81A,-C162A and-C81A/C162A, were treated with SNOC and incubated with the HeLa cytosol, followed by enrichment with nickel-agarose beads and detection with Western blot using an antibody against caspase-9. The left panel shows the Western blot image, and the right panel presents the interaction of caspase-9 with different SNOC-modified recombinant PCNAs. The relative immune-recognition intensities were estimated based on the ratios of the specific band volume against the total band volumes for caspase-9 in the upper panel (n = 3, *P<0.05 versus WT PCNA). (E) Comparison of the S-nitrosylated status of PCNA at Cys81 in SH-SY5Y cells with and without rotenone treatment. The S-nitrosylation status of PCNA at Cys81 is represented as the ratios of the S-nitrosylated Cys81 peptide to the sum of the peptides that contained Cys81, which were identified by LC-MS/MS (n = 3, *P<0.05).</p

Phenotype changes in SH-SY5Y cells in response to rotenone treatment.

<p>The dose (A) and time (B) responses of NO generated in SH-SY5Y cells that were treated with rotenone were analyzed. 18h treatment (A) and 500nM rotenone (B) were used for the gradient experiments. The NO contents are represented as the ratio of the intensity of DAF-FM fluorescence in the rotenone-treated group compared with the vehicle-treated group (average ratio ± SEM, n = 3, *P<0.05). Apoptosis assessment by flow cytometry for SH-SY5Y cells treated with or without 500nM rotenone for 16h (C). Dot plot showed annexin V-FITC in x-axis and PI in y-axis. Cells in the fourth quadrant undergoing early stage apoptosis are annexin V-positive/PI negative. And cells at late stage apoptosis or necrotic cells are both annexin V-FITC and PI positive. The left represents the untreated cells as the control. The apoptotic rates are shown as the average ratio ± SEM (n = 3).</p

Analysis of S-nitrosoproteomes in SH-SY5Y cells with and without rotenone treatment using CyDye switch/2D-DIGE and BST/Western blot.

<p>(A) The representative 2D-DIGE images. The internal standard (Cy3, green) and the target samples (Cy5, red) have been defined in the Methods section. The gel images were acquired by fluorescence scanning at λ_ex = 548 nm and λ_em = 560 nm for Cy3-labelled samples and at λ_ex = 641 nm and λ_em = 660 nm for Cy5-labelled samples. In the merged image, the circled spots represent the spots that differentially responded to rotenone treatment. (B) Comparison of the spot volumes for the seven differential proteins on 2D-DIGE. The spot fold-changes corresponding to the differential spots on <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0117546#pone.0117546.g002" target="_blank">Fig. 2A</a> were analyzed using PDQuest software version 8.0.1. The differential spots were defined as changes in spot volume over 1.5-fold in all the cases, and were excised and tryptic digested for protein identification with mass spectrometry (fold-changes of spot volumes ± SEM, n = 3, *P<0.05 versus vehicle-treated group). (C) Specificity and efficiency of biotin switch technique. SH-SY5Y cell lysates were treated with or without 200 μM SNOC followed by BST. Protein extract was loaded onto an SDS-PAGE. Western blot analysis was carried out, and the membrane was probed with anti-biotin. Control samples were subjected to PBS or SNOC but not to ascorbate. (D) Verification of the proteins with increased S-nitrosylation in SH-SY5Y cells treated with rotenone treatment. The proteins were extracted from SH-SY5Y cells with and without rotenone treatment and subjected to BST, and the biotinylated proteins were pulled down. The potentially S-nitrosylated proteins were examined by Western blot using the corresponding antibodies. The fold-changes are shown in the bar chart (n = 3, *P<0.05 versus vehicle-treated group).</p

Potential structural consequences of S-nitrosylation for PCNA.

<p>(A) The surface accessibility of S-nitrosylation sites. The sulfhydryl group (yellow) of Cys81 was exposed at the protein surface (left), but that of Cys162 was buried inside (right). (B) Molecular simulations of wild-type and SNOC-modified PCNAs. S-nitrosylation at Cys81 clearly affected the local structure of this residue, which may interfere with the interactions, but the Cys162 modification had no significant influence on the structure.</p